Kazia Therapeutics KZIA
NASDAQ KZIA
$9.27 -0.20 (-2.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kazia Therapeutics (KZIA) Cash from Discontinued Operations (2011 - 2013)

Updated

Kazia Therapeutics' Cash from Discontinued Operations was -$3.88 million in the quarter ended Dec 31, 2013.

Analysis

Kazia Therapeutics (KZIA) Cash from Discontinued Operations (2011 - 2013) Analysis & Trends

On a trailing twelve-month basis, Kazia Therapeutics' Cash from Discontinued Operations was -$1.03 million through Dec 31, 2013.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.87 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Kazia Therapeutics 68.33 Mn 68.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -3.88 Mn
Aug 30, 2013 -3.86 Mn
Jun 30, 2013 -4.15 Mn
Dec 31, 2012 10.86 Mn
Dec 31, 2011 1.08 Mn
API Access

Kazia Therapeutics Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=KZIA&period=max&api_key=YOUR_API_KEY